Document is current
Any future updates will be listed below
-
Authors
Morys, Filip https://orcid.org/0000-0001-8996-2676
Yu, Eric
Shishikura, Mari
Paquola, Casey
Vainik, Uku
Nave, Gideon https://orcid.org/0000-0001-6251-5630
Koellinger, Philipp
Gan-Or, Ziv
Dagher, Alain https://orcid.org/0000-0002-0945-5779
-
Funding
Funding for this research was provided by:
Fonds de Recherche du Québec - Santé
Eesti Teadusagentuur
- License Information
-
More Information
Article History
Received: 24 June 2022
Revised: 20 December 2022
Accepted: 22 December 2022
First Online: 3 January 2023
Conflict of interest
: Disclosure Statement: FM, EY, CP, MS, UV, GN, PK, and AD have nothing to declare. ZGO has received consulting fees from Idorsia, Ono Therapeutics, Neuron23, Handl Therapeutics, UBC, and Bial Biotech Inc. None of these companies were involved in any parts of preparing, drafting, and publishing this study.
